NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$325.55
−0.65%Margins
Gross margin
65.3%
EBITDA margin
-6.6%
EBIT margin
-10.7%
Net margin
-7.1%
FCF margin
2.6%
-10.6%
Return on equity
-7.2%
Return on assets
-14.1%
Return on invested capital
1.03x
Asset turnover
$228.2M
Cash from operations
$7.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026